TriangleNCT01435122 · OUTCOME
Time to Treatment Failure
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 12 Months
What was measured
Time to Treatment Failure: Time from administration of the initial dose of axitinib until study discontinuation for any reason (e.g., disease progression, toxicity, death, withdrawal of consent).
Analysis population: All participants.
Groups in this outcome
Axitinib Administration
The investigational drug used in this study is axitinib, and is available as tablets.
| Group | Source count |
|---|---|
| Axitinib Administration | 30 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Axitinib Administration | 9.6 | Not reported | 5.5 | 12 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 5.5
- upper Limit
- 12
- value
- 9.6
- denoms
- counts
- group Id
- OG000
- value
- 30
- units
- Participants
- description
- Time to Treatment Failure: Time from administration of the initial dose of axitinib until study discontinuation for any reason (e.g., disease progression, toxicity, death, withdrawal of consent).
- dispersion Type
- 95% Confidence Interval
- groups
- description
- The investigational drug used in this study is axitinib, and is available as tablets.
- id
- OG000
- title
- Axitinib Administration
- param Type
- MEDIAN
- population Description
- All participants.
- reporting Status
- POSTED
- time Frame
- 12 Months
- title
- Time to Treatment Failure
- type
- SECONDARY
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice